NXTM - Nxstage Medical, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Electromedical & Electrotherapeutic Apparatus - NXTM (1333170)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
75 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S51-0+0+1+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2018-02-20
NXTMSwan Winifred LSVP, GCS - Sale+OE$24.48-3,5009,770-26%-$85,680
D
2018-01-16
NXTMSwan Winifred LSVP, GCS - Sale+OE$24.88-3,50010,270-25%-$87,080
D
2017-12-20
NXTMSwan Winifred LSVP, GCS - Sale+OE$25.35-3,50010,770-25%-$88,725
D
2017-11-15
NXTMSwan Winifred LSVP, GCS - Sale+OE$25.73-3,50011,270-24%-$90,055
D
2017-10-20
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$27.50-4,03024,421-14%-$110,825
D
2017-10-20
NXTMSwan Winifred LSVP, GCS - Sale+OE$27.50-3,50011,770-23%-$96,250
2017-10-04
NXTMTurk Joseph E JrPresS - Sale$27.56-1,00072,903-1%-$27,560
D
2017-09-20
NXTMSwan Winifred LSVP, GCS - Sale+OE$27.27-3,50012,270-22%-$95,445
D
2017-09-20
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$27.27-4,30024,421-15%-$117,261
2017-09-05
NXTMTurk Joseph E JrPresS - Sale$27.95-1,00073,903-1%-$27,950
D
2017-08-21
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$29.22-4,30024,421-15%-$125,646
D
2017-08-15
NXTMSwan Winifred LSVP, GCS - Sale+OE$29.21-3,50012,770-22%-$102,235
2017-08-10
NXTMTurk Joseph E JrPresS - Sale$29.26-1,00074,903-1%-$29,260
D
2017-08-07
NXTMTurk Joseph E JrPresS - Sale+OE$29.64-24,00075,903-24%-$711,300
D
2017-08-03
NXTMTurk Joseph E JrPresS - Sale+OE$22.98-7,00075,903-8%-$160,860
D
2017-07-20
NXTMSwan Winifred LSVP, GCS - Sale+OE$24.16-3,50013,270-21%-$84,560
D
2017-07-20
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$24.16-4,30024,421-15%-$103,888
2017-07-05
NXTMTurk Joseph E JrPresS - Sale$25.19-1,00075,903-1%-$25,190
2017-06-14
NXTMTurk Joseph E JrPresS - Sale$23.74-1,00075,903-1%-$23,740
D
2017-06-20
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$23.29-4,30025,337-15%-$100,147
D
2017-06-15
NXTMSwan Winifred LSVP, GCS - Sale+OE$23.14-3,50013,770-20%-$80,990
D
2017-06-08
NXTMTurk Joseph E JrPresS - Sale+OE$23.59-2,25077,903-3%-$53,078
D
2017-05-22
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$21.36-4,30025,337-15%-$91,848
D
2017-05-15
NXTMSwan Winifred LSVP, GCS - Sale+OE$21.94-3,50014,270-20%-$76,790
D
2017-05-10
NXTMTurk Joseph E JrPresS - Sale+OE$23.59-25077,9030%-$5,898-2
2017-05-03
NXTMTurk Joseph E JrPresS - Sale$29.95-1,00077,903-1%-$29,9500-17
2017-04-20
NXTMBurbank Jeffrey HCEOS - Sale$27.28-3,000939,0860%-$81,840+3+7
D
2017-04-20
NXTMSwan Winifred LSVP, GCS - Sale+OE$27.28-3,50014,770-19%-$95,480-1+7
D
2017-04-20
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$27.28-4,30025,337-15%-$117,304-1+7
2017-04-19
NXTMBurbank Jeffrey HCEOS - Sale$26.65-3,000942,0860%-$79,950-1+7
2017-04-13
NXTMTurk Joseph E JrPresS - Sale$26.10-1,00078,903-1%-$26,100+3+7
D
2017-04-03
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale+OE$26.60-14,39713,606-51%-$382,960-1+1+3
2017-03-22
NXTMBurbank Jeffrey HCEOS - Sale$27.42-3,000945,0860%-$82,260+2+1+6
D
2017-03-20
NXTMSwan Winifred LSVP, GCS - Sale+OE$27.66-15,72315,270-51%-$434,898-3-1+4
D
2017-03-20
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$27.66-4,30025,337-15%-$118,938-3-1+4
2017-03-21
NXTMBurbank Jeffrey HCEOS - Sale$27.72-3,000948,0860%-$83,160-3-1+4
2017-03-16
NXTMMoore Craig WDirS - Sale$27.93-1,00094,943-1%-$27,9300-4-7
2017-03-08
NXTMTurk Joseph E JrPresS - Sale$27.53-1,00079,903-1%-$27,530+2+1-4
D
2017-03-07
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale+OE$27.75-20,00016,086-55%-$555,000-1+1-5
D
2017-03-06
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale+OE$28.01-6,39016,086-28%-$178,984-10-5
2017-02-23
NXTMBurbank Jeffrey HCEOS - Sale$28.97-7,500936,249-1%-$217,275+1-2-9
2017-02-22
NXTMBurbank Jeffrey HCEOS - Sale$29.01-7,500943,749-1%-$217,5750+1-10
D
2017-02-21
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$29.26-4,30018,741-19%-$125,8180+1-10
D
2017-02-17
NXTMTurk Joseph E JrPresS - Sale+OE$29.66-6,00069,280-8%-$177,960-1+1-6
D
2017-02-15
NXTMSwan Winifred LSVP, GCS - Sale+OE$28.01-16,04910,473-61%-$449,532+1-1-4
2017-02-14
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale$28.28-2,44817,315-12%-$69,229+1-1-4
DM
2017-02-09
NXTMTurk Joseph E JrPresS - Sale+OE$28.36-3,50069,280-5%-$99,2450+3-3
2017-02-08
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale$27.61-3,05419,763-13%-$84,321+2+20
2017-02-07
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale$27.54-3,11722,817-12%-$85,8420+3-1
DM
2017-02-03
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale+OE$26.87-16,28325,934-39%-$437,603+1+3+1
DM
2017-02-01
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale+OE$26.68-37,34729,217-56%-$996,5400+3+5
D
2017-02-02
NXTMTurk Joseph E JrPresS - Sale+OE$26.19-15,66970,280-18%-$410,3710+3+5
DM
2017-01-24
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale+OE$26.05-42,00040,564-51%-$1,094,250+1+1+11
D
2017-01-20
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$26.19-4,30018,741-19%-$112,6170+3+13
D
2017-01-20
NXTMSwan Winifred LSVP, GCS - Sale+OE$26.19-3,50010,973-24%-$91,6650+3+13
DM
2017-01-19
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale+OE$26.20-21,61540,564-35%-$566,3620+3+13
2017-01-18
NXTMBurbank Jeffrey HCEOS - Sale$27.63-7,500867,616-1%-$207,225-6-7+5
2017-01-18
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale$27.58-8,18347,179-15%-$225,687-6-7+5
2017-01-17
NXTMBrown Robert S.Pres, NxStage Kidney CareS - Sale$27.72-10,80555,362-16%-$299,515+1-6+2
2017-01-17
NXTMBurbank Jeffrey HCEOS - Sale$27.52-7,500875,116-1%-$206,400+1-6+2
2017-01-13
NXTMTurk Joseph E JrPresS - Sale$28.00-7,50070,280-10%-$210,000+1-6+2
2017-01-11
NXTMTurk Joseph E JrPresS - Sale$27.77-1,00077,780-1%-$27,77000+1
D
2016-12-20
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$25.55-4,30018,741-19%-$109,8650+5+5
D
2016-12-15
NXTMSwan Winifred LSVP, GCS - Sale+OE$25.91-3,50011,473-23%-$90,685-1-3+9
2016-12-14
NXTMBurbank Jeffrey HCEOS - Sale$25.68-7,500882,616-1%-$192,600-1-4+9
2016-12-13
NXTMBurbank Jeffrey HCEOS - Sale$25.42-7,500890,116-1%-$190,6500-2+8
2016-12-13
NXTMTurk Joseph E JrPresS - Sale$25.42-1,00078,780-1%-$25,4200-2+8
DM
2016-11-25
NXTMTurk Joseph E JrPresS - Sale+OE$26.01-12,16979,780-13%-$316,485-4-50
2016-11-23
NXTMBurbank Jeffrey HCEOS - Sale$24.01-7,500897,616-1%-$180,075+3-2-1
2016-11-21
NXTMGiannini Daniel ADirS - Sale$25.96-6,44963,193-9%-$167,416+3+5+1
D
2016-11-22
NXTMSwan Winifred LSVP, GCS - Sale+OE$25.51-3,00011,973-20%-$76,530+3+5+1
2016-11-22
NXTMBurbank Jeffrey HCEOS - Sale$25.51-7,500905,116-1%-$191,325+3+5+1
D
2016-11-21
NXTMTowse Matthew WSVP, Chief Financial OfficeS - Sale+OE$26.23-4,30018,741-19%-$112,789-50-4
2016-11-17
NXTMTurk Joseph E JrPresS - Sale$25.97-1,00079,780-1%-$25,970-2-1-3
2016-11-16
NXTMTurk Joseph E JrPresS - Sale$26.26-22,50080,780-22%-$590,850+1-6-1
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top